Background illustration for clinical trials search

Follicular Lymphoma Clinical Trials

Browse 120 follicular lymphoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of 177Lu-PSMA-617 in People With Gliomas

for
Glioma, Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4),
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07223034

Phase1, Recruiting

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06410248

Phase1, Recruiting

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

for
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma,
Location: New York NY, Montreal, Toronto, Rochester MN,
Sponsor: Mayo Clinic

Sex: All

Age: 0+

Code: NCT06689956

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

for
Recurrent Malignant Glioma, Recurrent WHO Grade 3 Glioma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06964737

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

for
Grade 2 Meningioma, Intracranial Meningioma
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT03180268

Phase3, Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

for
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell,
Location: Philadelphia PA, Miami FL, Buffalo NY, Cleveland OH,
Sponsor: Oncotartis, Inc.

Sex: All

Age: 18+

Code: NCT03921879

Phase1, Recruiting

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

for
Follicular Helper T-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07278856

Phase1, Recruiting

A Registry for People With T-cell Lymphoma

for
T-cell Lymphoma, NK-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT05978141

Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma,
Location: New York NY, Pittsburgh PA, Detroit MI, Ann Arbor MI,
Sponsor: SciTech Development, Inc.

Sex: All

Age: 18+

Code: NCT04234048

Phase1, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

for
Angioimmunoblastic T-cell Lymphoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT04803201

Phase2, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase3, Recruiting

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

for
Follicular Helper T-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07293403

Phase2, Recruiting

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

for
Folliculotropic Mycosis Fungoides,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT03011814

Phase1, Phase2, Recruiting

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

for
Folliculotropic Mycosis Fungoides,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04930653

Phase2, Recruiting

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

for
Vulvar Diseases, HPV Infection, Vulvar HSIL,
Location: Fort Myers FL, Mayfield Heights OH, Cleveland OH,
Sponsor: Frantz Viral Therapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06075264

Phase2, Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

for
Invasive Ductal Breast Carcinoma,
Location: Commack NY, Norwalk CT, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 45+

Code: NCT04084730

Phase2, Recruiting

Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity

for
Peripheral Neuropathy With Type 2 Diabetes,
Location: Jacksonville FL
Sponsor: RxFunction Inc.

Sex: All

Age: 60+

Code: NCT07554443

Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

for
Mantle Cell Lymphoma, Follicular Lymphoma,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04223765

Phase1, Recruiting